
Gene, Journal Year: 2024, Volume and Issue: 940, P. 149199 - 149199
Published: Dec. 27, 2024
Pre-existing of pulmonary tuberculosis (PTB) poses increased lung cancer risk, yet the molecular mechanisms remain inadequately understood. This study sought to elucidate potential by performing comprehensive analyses differentially expressed genes (DEGs) in peripheral blood mononuclear cells (PBMCs) from patients with PTB, adenocarcinoma (LUAD), and squamous cell carcinoma (LUSC). Microarray assays were employed analyze DEGs PBMCs these patients. The revealed that, compared healthy controls, number LncRNA LUAD, LUSC 801, 8,541, 7,796, respectively. Similarly, mRNA 629, 4,865, 4,438, These transcripts represent significant resources for identifying diagnostic differential biomarkers PTB. Pathways enriched dysregulated mRNAs identified through GO KEGG pathway analyses. results indicated that 9 pathways including NOD-like receptor signaling pathway, cancer, MAPK co-enriched across groups, providing insights into which PTB may increase risk development progression.
Language: Английский